Article Text

Download PDFPDF

Design of treatment trials for functional gastrointestinal disorders
Free

Abstract

Until recently many clinical trials of functional gastrointestinal disorders (FGIDs) suffered from important weaknesses in trial design, study execution, and data analysis. This makes it difficult to determine whether truly efficacious therapies exist for these disorders. One of the important methodologic problems is the absence of validated outcome measures and lack of consensus among stakeholders on how to measure outcome. Currently much of the effort is being put into the development of validated outcome measures for several of the FGIDs. The randomized, controlled trial with parallel groups is the design of choice. In this report, guidelines are given for the basic architecture of intervention studies of FGIDs. Further studies on design issues are required to ensure the recommendations will become evidence based in the future.

  • clinical trial
  • random allocation
  • functional gastrointestinal disorder(s)
  • dyspepsia
  • functional dyspepsia
  • irritable bowel syndrome
  • evidence based medicine
  • study design
  • outcome measures
  • Rome II
View Full Text

Statistics from Altmetric.com

Footnotes

  • Abbreviations used in this paper:
    FGID
    functional gastrointestinal disorder
    IBS
    irritable bowel syndrome
    VAS
    visual analogue scales
    ITT
    intention-to-treat
    MCID
    minimal clinically important difference

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.